A medical research laboratory where scientists in white lab coats are researching treatments for genetic keratinization disorders. Align Technology, Inc. (NASDAQ:ALGN) filed patent infringement ...

Pattern Group Inc., an e-commerce firm that resells goods on marketplaces such as Amazon.com Inc.’s, filed for an initial public offering, disclosing growing revenue and profit. The Lehi, Utah-based ...

U.S. Attorney General Pam Bondi speaks at a press briefing with and U.S. President Donald Trump U.S. Deputy Attorney General Todd Blanche in the James S. Brady Press Briefing Room in the White House ...

A Pittsburgh-region trucking company filed for voluntary Chapter 11 bankruptcy protection in federal bankruptcy court. CLB Trucking Inc., 959 Old State Route 66, Greensburg, made the filing Friday in ...

House Oversight and Government Reform Committee ranking member Robert Garcia (D-Calif.) said the plan for the Department of Justice to respond in “batches” to the committee’s subpoena for files ...

WASHINGTON - Though lawmakers are on their annual one-month summer break, the controversy surrounding convicted late sex offender Jeffrey Epstein hasn’t left their minds. “The Epstein case will not be ...

BYD wants to attract younger drivers with its latest electric SUV. The new BYD Atto 2 launched in Hong Kong on Friday with prices starting under $22,000, or about 30% cheaper than Tesla’s most ...

Los Angeles County District Attorney Nathan Hochman filed a 132-page response opposing the Menendez brothers’ bid for a new trial, the latest in a years-long fight with defense attorneys who have ...

The FBI went through the Epstein files and redacted Donald Trump’s name, according to the “FOIA Files” newsletter by reporter Jason Leopold, published in Bloomberg Friday. It was previously reported ...

President Donald Trump’s name was redacted “numerous times” in the Jeffrey Epstein files by an FBI team determining which information potentially could be released to the public, according to an ...

Submission is supported by 24-week results from the Phase 3b APEX study in adults with active psoriatic arthritis treated with TREMFYA®, the only dual-acting IL-23 inhibitor HORSHAM, Pa., July 29, ...